- Conditions
- Evaluating Attitudes Toward HPV Vaccinations in Pharmacies, Evaluating the Provision of HPV Vaccines in a Pharmacy
- Interventions
- HPV vaccine
- Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 11 Years to 18 Years
- Enrollment
- 1,509 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2018
- U.S. locations
- 2
- States / cities
- Durham, North Carolina
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–36
of 36
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Gardasil Vaccine, Stem Cell Transplant, Immunogenicity
- Interventions
- Gardasil
- Biological
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 64 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2016
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- HIV Infections, Sexually Transmitted Diseases
- Interventions
- Quadrivalent HPV vaccine
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 13 Years to 45 Years · Female only
- Enrollment
- 319 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 56
- States / cities
- Birmingham, Alabama • Alhambra, California • La Jolla, California + 37 more
- Conditions
- Human Papilloma Virus
- Interventions
- Gardasil9
- Drug
- Lead sponsor
- Boston Medical Center
- Other
- Eligibility
- 4 Years to 8 Years
- Enrollment
- 155 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Human Papillomavirus Infection
- Interventions
- Quadrivalent human papillomavirus vaccine on-time administration, Quadrivalent human papillomavirus vaccine delayed administration
- Biological
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years to 23 Years · Female only
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Cervical Cancer, Hpv, Warts
- Interventions
- Quadrivalent HPV for types 6, 11, 16 and 18
- Biological
- Lead sponsor
- Medstar Health Research Institute
- Other
- Eligibility
- 9 Years to 17 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 2
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Recurrent Respiratory Papillomatosis
- Interventions
- Human Papillomavirus Vaccine
- Biological
- Lead sponsor
- University of Missouri-Columbia
- Other
- Eligibility
- 18 Years to 80 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Columbia, Missouri
- Conditions
- Vaccine Acceptance, Social Acceptance, Acceptance Processes, Health Behavior, Human Papillomavirus
- Interventions
- Educational Video with Male or Female Narrator
- Other
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 11 Years and older
- Enrollment
- 110 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2018
- U.S. locations
- 2
- States / cities
- Flourtown, Pennsylvania • Philadelphia, Pennsylvania
- Conditions
- Human Papillomavirus
- Interventions
- Gardasil
- Biological
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Other
- Eligibility
- 27 Years to 45 Years · Male only
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2020
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Vaccines, Meningococcal Vaccines
- Interventions
- rLP2086 and Gardasil, rLP2086, Gardasil
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 11 Years to 17 Years
- Enrollment
- 2,499 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2013
- U.S. locations
- 87
- States / cities
- Daphne, Alabama • Chandler, Arizona • Jonesboro, Arkansas + 57 more
- Conditions
- Infections, Papillomavirus, Papillomavirus Vaccines
- Interventions
- GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM), Gardasil ® (Merck & Co. Inc), Placebo
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 1,106 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2012
- U.S. locations
- 40
- States / cities
- Chandler, Arizona • San Diego, California • San Francisco, California + 36 more
- Conditions
- Healthy Volunteers
- Interventions
- quadrivalent HPV vaccine
- Drug
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years to 30 Years · Female only
- Enrollment
- 203 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia